High-dose oral dexamethasone therapy for chronic childhood idiopathic thrombocytopenic purpura.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8636831.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Because high-dose oral dexamethasone therapy has been reported to be effective for adults with idiopathic thrombocytopenic purpura, we assessed the short-term efficacy and toxicity of dexamethasone in seven children with chronic or refractory idiopathic thrombocytopenic purpura. Dexamethasone therapy was effective and well tolerated; further long-term studies are warranted.
Medical subject headings
- Anti-Inflammatory Agents
- Dexamethasone
- Purpura, Thrombocytopenic